EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Third-generation cephalosporin resistant Escherichia coli in dogs and cats in Germany in 2019–2021

Stefanie Katharina Frenzer, Leonie Feuer, Alexander Bartel iD, Astrid Bethe, Antina Lübke-Becker, Babette Klein, Wolfgang Bäumer, Roswitha Merle

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0309554 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Stefanie Katharina Frenzer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Veterinary Epidemiology and Biostatistics, School of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Escherichia coli, Cephalosporins, Anti-Bacterial Agents, Microbial Sensitivity Tests. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Ernährung und Landwirtschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Antimicrobial resistance (AMR) poses a worldwide challenge, threatening global health. The objective of this research was to determine the 3 rd generation cephalosporin resistance (3GCR) proportion in Escherichia (E . ) coli isolated from clinical samples of dogs and cats in Germany.

Methods

The study utilized result data from antimicrobial susceptibility testing (AST) of isolates obtained from diagnostic samples collected from dogs and cats send in for bacterial examination. Data includes AST results from 3,491 veterinary practices in Germany spanning the years 2019 to 2021, representing 33.1% of practices and clinics nationwide. Out of 175,171 clinical samples, a total of 25,491 E. coli strains (14,6%) were evaluated for their susceptibility to antimicrobials, in particular the 3 rd generation cephalosporin cefovecin, but also aminoglycosides (gentamicin, GEN), fluoroquinolones (enrofloxacin, ENR), tetracyclines (doxycycline), phenicols (chloramphenicol), folate pathway inhibitors (sulfamethoxazole + trimethoprim), and nitrofurans (nitrofurantoin).

Results

The cefovecin resistance proportion was 11.6% in the study period. Geographical analysis showed local variations in 3GCR in E. coli of ±3%. Regarding all E. coli isolates investigated, resistance proportions were observed as follows: 12% for sulfamethoxazole-trimethoprim, 7% for enrofloxacin, 8% for chloramphenicol and 4% for gentamicin. Notably, 3GCR E. coli showed significantly higher resistance proportions, specifically 30% for sulfamethoxazole-trimethoprim, 28% for chloramphenicol, 18% for enrofloxacin and 14% for gentamicin.

Conclusions

This study represents the first of its kind to utilize an extensive dataset encompassing dogs and cats across Germany. Companion animals have close contact to their owners and transmission of 3GCR between them is likely as well as acquisition from other environmental sources. Resistance proportions (6.7%) against the antibiotic ceftazidime as reported by the German AMR surveillance for human medicine were lower than in our veterinary data. Our study provides an overview of the current 3GCR resistance proportion in Germany and demonstrates the importance of integrated AMR monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliCephalosporinsAnti-Bacterial AgentsMicrobial Sensitivity TestsEscherichia coli InfectionsDog DiseasesCat DiseasesCatsDogsAnimalsGermanyCephalosporin Resistance

Substanzen

CephalosporinsAnti-Bacterial Agentscefovecin

Autor:innen und Institutionen

  • Institute of Veterinary Epidemiology and Biostatistics, School of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
  • Veterinary Centre for Resistance Research, Freie Universität Berlin, Berlin, Germany.
  • Institute of Pharmacology and Toxicology, School of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
  • Institute of Microbiology and Epizootics, School of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
  • LABOKLIN GmbH und Co. KG, Bad Kissingen, Germany.

ORCID-Profile: Alexander Bartel

Förderung

  • Bundesministerium für Ernährung und Landwirtschaft

Zitieren

APA

Frenzer, S. K., Feuer, L., Bartel, A., Bethe, A., Lübke-Becker, A., Klein, B., Bäumer, W., & Merle, R. (2024). Third-generation cephalosporin resistant Escherichia coli in dogs and cats in Germany in 2019–2021. PLOS ONE. https://doi.org/10.1371/journal.pone.0309554

Vancouver

Frenzer SK, Feuer L, Bartel A, Bethe A, Lübke-Becker A, Klein B, et al. Third-generation cephalosporin resistant Escherichia coli in dogs and cats in Germany in 2019–2021. PLOS ONE. 2024. doi:10.1371/journal.pone.0309554

BibTeX
@article{Frenzer2024,
  author = {Frenzer, Stefanie Katharina and Feuer, Leonie and Bartel, Alexander and Bethe, Astrid and Lübke-Becker, Antina and Klein, Babette and Bäumer, Wolfgang and Merle, Roswitha},
  title = {Third-generation cephalosporin resistant Escherichia coli in dogs and cats in Germany in 2019–2021},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0309554}
}
Kostenlos starten →